Cite Filings / CTNM / 0000919574-24-002557
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13G

Amended Statement of Ownership

Contineum Therapeutics, Inc. · Filed 2024-04-15 · Acc 0000919574-24-002557

Documents 1

  • SC 13G Amended Statement of Ownership , d11024986_13-g.htm

Around this filing

  • 2024-04-15 SC 13G Amended Statement of Ownership
  • 2024-04-15 SC 13G Amended Statement of Ownership
  • 2024-04-11 4 10% owner acquired 542,628 shares (conversion)
  • 2024-04-10 SC 13G Amended Statement of Ownership
  • 2024-04-10 3 Initial Statement of Ownership
  • 2024-04-09 8-K Bylaws or fiscal year change
  • 2024-04-09 S-8 Securities Offered to Employees in Benefit Plans

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · JANUS HENDERSON GROUP Ltd. 4.6%
  2. 2026-11-16 SCHEDULE 13G/A · BALYASNY ASSET MANAGEMENT L.P. 7.35%
  3. 2026-10-28 SCHEDULE 13G/A · Franklin Templeton, Inc. 5.2%
Loading d11024986_13-g.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…